As GLP-1 receptor agonists (GLP-1s) like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) become increasingly common in the treatment of diabetes, obesity, and cardiovascular disease, retina specialists are paying close attention to whether the drug therapies may influence ocular disease in already high-risk patients
reported its effect on diabetes-induced alterations [154]
Hello Dr
Also addition of solution of glutathione (GSH) transferase in the reaction mixture caused a marked increase in the rate of reaction compared to the non-enzymatic, showing monobromobimane was a substrate for this enzyme ( Figure 1 )
By staying informed and adaptable, breweries can navigate these changes and continue to thrive in a shifting market landscape
Pastorello E, Stocchi L, Bigi A, Pravettoni V, Schilke ML, Valente D, & Zanussi C (1989) Value and limits of diagnostic tests in food hypersensitivity